Is This Company the Tesla of Gene Sequencing?
Warren Buffett and Charlie Munger have called them "moats." Harvard Business School professor Michael Porter called them "barriers to entry" in his famous 1979 article "How Competitive Forces Shape Strategy."
Factors that make it difficult for competitors to enter a market mean enormous power for any company that's already there. Typically, with power comes profit.
Illumina (NASDAQ: ILMN) has established one of the most powerful moats in recent memory. A maker of equipment and tools for genetic sequencing, the company has rewarded investors handsomely since its July 2000 IPO. Looking to the future, can it maintain its market-leading position and continue paying off for shareholders?
Source Fool.com
